Sunoco LP Common Units (SUN) Q3 2025 Earnings Call Transcript — Neutral

SUN   Seeking Alpha — November 05, 2025

Sunoco LP Common Units ( SUN ) Q3 2025 Earnings Call November 5, 2025 10:00 AM EST Company Participants Scott Grischow Karl Fails - Executive VP & COO of Sunoco GP LLC Joseph Kim - President, CEO & Director of Sunoco GP LLC Austin Harkness - Executive VP & Chief Commercial Officer of Sunoco GP LLC Conference Call Participants Spiro Dounis - Citigroup Inc., Research Division Justin Jenkins - Raymond James & Associates, Inc., Research Division Theresa Chen - Barclays Bank PLC, Research Division Elias Jossen - JPMorgan Chase & Co, Research Division Ned Baramov - Wells Fargo Securities, LLC, …

image for news Sunoco LP Common Units (SUN) Q3 2025 Earnings Call Transcript

iA Financial Corporation Inc. (IAG:CA) Q3 2025 Earnings Call Transcript — Neutral

IAFNF  IAG   Seeking Alpha — November 05, 2025

iA Financial Corporation Inc. ( IAG:CA ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Caroline Drouin - Head of Investor Relations Denis Ricard - CEO, President & Director Eric Jobin - Executive VP, CFO, & Chief Actuary Stephan Bourbonnais - Executive Vice President of Wealth Management Sean O'Brien - Chief Growth Officer of US Operations Conference Call Participants Gabriel Dechaine - National Bank Financial, Inc., Research Division Doug Young - Desjardins Securities Inc., Research Division Tom MacKinnon - BMO Capital Markets Equity Research Paul Holden - CIBC Capital Markets, Research Division Mehmed Rizvanovic - Scotiabank …

image for news iA Financial Corporation Inc. (IAG:CA) Q3 2025 Earnings Call Transcript

CGI Inc. (GIB.A:CA) Q4 2025 Earnings Call Transcript — Neutral

GIB   Seeking Alpha — November 05, 2025

CGI Inc. ( GIB.A:CA ) Q4 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Kevin Linder - Senior Vice President of Investor Relations Steve Perron - Executive VP & CFO François Boulanger - President, CEO & Director Conference Call Participants Thanos Moschopoulos - BMO Capital Markets Equity Research Robert Young - Canaccord Genuity Corp., Research Division Jerome Dubreuil - Desjardins Securities Inc., Research Division Stephanie Price - CIBC Capital Markets, Research Division Surinder Thind - Jefferies LLC, Research Division Paul Treiber - RBC Capital Markets, Research Division Richard Tse - National Bank Financial, Inc., Research Division Suthan …

image for news CGI Inc. (GIB.A:CA) Q4 2025 Earnings Call Transcript

DG vs. ROST: Which Stock Is the Better Value Option? — Positive

DG  ROST   Zacks Investment Research — November 05, 2025

Investors with an interest in Retail - Discount Stores stocks have likely encountered both Dollar General (DG) and Ross Stores (ROST). But which of these two companies is the best option for those looking for undervalued stocks?

image for news DG vs. ROST: Which Stock Is the Better Value Option?

SGC vs. RVLV: Which Stock Is the Better Value Option? — Positive

RVLV  SGC   Zacks Investment Research — November 05, 2025

Investors looking for stocks in the Textile - Apparel sector might want to consider either Superior Group (SGC) or Revolve Group (RVLV). But which of these two companies is the best option for those looking for undervalued stocks?

image for news SGC vs. RVLV: Which Stock Is the Better Value Option?

GTM or FFIV: Which Is the Better Value Stock Right Now? — Neutral

FFIV  GTM   Zacks Investment Research — November 05, 2025

Investors looking for stocks in the Internet - Software sector might want to consider either ZoomInfo (GTM) or F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now?

image for news GTM or FFIV: Which Is the Better Value Stock Right Now?

AYI vs. SPXC: Which Stock Is the Better Value Option? — Neutral

AYI  SPXC   Zacks Investment Research — November 05, 2025

Investors looking for stocks in the Technology Services sector might want to consider either Acuity (AYI) or SPX Technologies (SPXC). But which of these two stocks is more attractive to value investors?

image for news AYI vs. SPXC: Which Stock Is the Better Value Option?

KGC or FNV: Which Is the Better Value Stock Right Now? — Positive

FNV  KGC   Zacks Investment Research — November 05, 2025

Investors looking for stocks in the Mining - Gold sector might want to consider either Kinross Gold (KGC) or Franco-Nevada (FNV). But which of these two companies is the best option for those looking for undervalued stocks?

image for news KGC or FNV: Which Is the Better Value Stock Right Now?

Amgen: Q3 Earnings Indicate Strong Emphasis On R&D — Positive

AMGN   Seeking Alpha — November 05, 2025

Amgen remains a compelling long-term buy, supported by robust R&D investment and a promising drug pipeline for future growth. AMGN delivered strong Q3 results, with double-digit revenue and volume growth across key segments, and maintains an attractive 3.2% dividend yield. Valuation metrics remain favorable, and management's focus on R&D and operating margins positions AMGN to capture expanding therapeutic markets.

image for news Amgen: Q3 Earnings Indicate Strong Emphasis On R&D

3 Sports Betting Stocks to Watch Before Earnings — Neutral

DKNG  FLUT  PENN   Schaeffers Research — November 05, 2025

Sports betting giants DraftKings Inc (NASDAQ:DKNG) and PENN Entertainment Inc (NASDAQ:PENN) will report third-quarter earnings tomorrow, the former after the close and the latter before the open.

image for news 3 Sports Betting Stocks to Watch Before Earnings

What's Going On With Performance Food Stock Today? — Neutral

PFGC   Benzinga — November 05, 2025

Performance Food Group Company (NYSE:PFGC) reported on Wednesday its first-quarter results.

image for news What's Going On With Performance Food Stock Today?

Plains All American Q3 Earnings Beat Estimates, Sales Decline Y/Y — Positive

PAA   Zacks Investment Research — November 05, 2025

PAA beats Q3 earnings estimates as cost reductions lift profits despite a 7% drop in sales.

image for news Plains All American Q3 Earnings Beat Estimates, Sales Decline Y/Y

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve? — Positive

VRTX   Zacks Investment Research — November 05, 2025

VRTX's new drugs deliver a mixed Q3 performance. Alyftrek sales surge.

image for news VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

Charles River: Mixed Q3 As Strategic Review Disappoints — Negative

CRL   Seeking Alpha — November 05, 2025

Charles River Laboratories remains a "Hold" as strategic review yields minimal change and a sale is unlikely. CRL faces slow organic growth, shrinking backlog, and ongoing pressure in its core DSA segment, with limited near-term demand recovery. Cost-cutting, selective divestitures, and a new $1 billion buyback authorization offer some support, but growth headwinds persist.

image for news Charles River: Mixed Q3 As Strategic Review Disappoints

Stardust's Strategic Lithium Deal Could Be a Game-Changer — Positive

SDST   MarketBeat — November 05, 2025

A strategic move by Stardust Power NASDAQ: SDST to secure a domestic lithium supply sent a clear signal to the market, sparking a surge in Stardust's stock price and a significant increase in trading volume.

image for news Stardust's Strategic Lithium Deal Could Be a Game-Changer

Pure Storage Flies on Five Outlier Signals Since September — Positive

PSTG   FXEmpire — November 05, 2025

Pure Storage, Inc. (PSTG) shares up 23% since September after five outlier inflow signals.

image for news Pure Storage Flies on Five Outlier Signals Since September

MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened — Positive

MIRM   Zacks Investment Research — November 05, 2025

Mirum posts third-quarter profit and stronger revenues on surging Livmarli demand, while tightening its 2025 sales outlook.

image for news MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened

Berkshire Hathaway Q3 Earnings Beat, Revenues Miss, Both Rise Y/Y — Positive

BRK-A  BRK-B   Zacks Investment Research — November 05, 2025

Berkshire Hathaway posts a 33.8% surge in Q3 operating earnings, driven by strong insurance and retail gains despite a slight revenue miss.

image for news Berkshire Hathaway Q3 Earnings Beat, Revenues Miss, Both Rise Y/Y

Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential — Positive

HROW   Seeking Alpha — November 05, 2025

Harrow, Inc. is an ophthalmology company with strong revenue growth, ambitious targets, and a diverse product portfolio including Vevye and Iheezo. HROW targets $280M in 2025 revenue and >$250M per quarter by Q4 2027, leveraging recent acquisitions and biosimilar partnerships. Despite low profitability and modest cash reserves, HROW's experienced management, robust pipeline, and expanding market share support a bullish long-term outlook.

image for news Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential

Weyco Group, Inc. (WEYS) Q3 2025 Earnings Call Transcript — Neutral

WEYS   Seeking Alpha — November 05, 2025

Weyco Group, Inc. ( WEYS ) Q3 2025 Earnings Call November 5, 2025 11:00 AM EST Company Participants Judy Anderson - VP, CFO & Secretary Thomas Florsheim - Chairman & CEO John Florsheim - President, COO, Assistant Secretary & Director Conference Call Participants David Wright - Henry Investment Trust, L.P Presentation Operator Thank you for standing by. At this time, I would like to welcome everyone to Weyco Group, Inc. Third Quarter 2025 Earnings Conference Call.

image for news Weyco Group, Inc. (WEYS) Q3 2025 Earnings Call Transcript